• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGMR373720J
Device Problems Malposition of Device (2616); Material Split, Cut or Torn (4008)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 08/21/2020
Event Type  malfunction  
Event Description
The following information was reported to gore: on (b)(6) 2020, this patient underwent endovascular treatment using gore® tag® conformable thoracic stent graft with active control system (ctag ac) for descending thoracic aortic aneurysm.The ctag ac was fully deployed at the target location.No angulation control was used.During removal of lock wire, some resistance was felt, and the lock wire broke.Then, during removal of angulation assembly handle, the angulation fiber broke (1900-e).The access hatch was opened, the lock wire was completely removed using forceps with some resistance.The angulation fiber was also completely removed.Since an attempt was made to remove the angulation assembly handle before the lock wire was completely removed, which resulted in unintended angulation (1934-e) and loss of proximal sealing.A second ctag ac was deployed to extend the device proximally.No adverse event was reported, and the patient tolerated the procedure.The physician stated as follows: there is tortuosity at the diaphragm level.The lock wire of the first device was quite resistant.The lock wire of the second device could be pulled out smoothly without resistance.Please investigate the cause.The reported device will be returned to gore for further investigation.A physician letter was requested.
 
Manufacturer Narrative
H6: code 3252 - evaluation of returned device revealed broken lock wire.H6: code 4307 - evaluation of returned device revealed broken lock wire.The gore® tag® conformable thoracic stent graft with active control system (cmds) device evaluation showed the following: the lockwire broke off the lockwire connector.The lockwire was completely removed from the device and catheter.There were kinks in the lockwire approximately 5.5cm and 6cm from the ferrule, likely from removing the lockwire through the back up hatch.The angulation fiber connector was broken, likely due to attempting to remove the angulation fibers prior to removing the lockwire.Based off the device evaluation, the report of the lockwire and angulation fibers breaking could be confirmed.No root cause could be identified for the broken lockwire and angulation connectors.Based on the evaluation, no manufacturing deficiency could be identified.Per md145952 rev.20 no capa request is required.Events will continue to be monitored per md24024.
 
Manufacturer Narrative
H6: code 4315 cause not established.Original code of 4307 was incorrect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10535605
MDR Text Key207000469
Report Number2017233-2020-01256
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 03/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/15/2023
Device Catalogue NumberTGMR373720J
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2020
Initial Date Manufacturer Received 08/21/2020
Initial Date FDA Received09/15/2020
Supplement Dates Manufacturer Received08/21/2020
08/21/2020
Supplement Dates FDA Received11/30/2020
03/02/2021
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age85 YR
-
-